Lilly Eyes India as Strategic Export Base as Mounjaro Demand Surges
Eli Lilly and Company is strengthening its presence in India and evaluating the country as a strategic export base amid rising demand for its blockbuster diabetes and weight-loss therapy Mounjaro, as reported by Reuters.




















